Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

v3.19.3
NET LOSS PER SHARE (Tables)
9 Months Ended
Sep. 30, 2019
NET LOSS PER SHARE  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following potentially dilutive securities have been excluded from the computation of diluted net income (loss) per share since their inclusion would be antidilutive:

 

 

 

 

 

 

 

Nine Months Ended

 

 

September 30, 

 

    

2019

    

2018

Warrants

 

9,268,352

 

5,318,747

Preferred shares as convertible into common stock

 

537,500

 

 —

Stock options

 

610,714

 

56,354

Non-vested restricted stock

 

9,334

 

25,334

Total potentially dilutive shares

 

10,425,900

 

5,400,435